| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.073 | 0.1 |